A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia (NCT07293728)

🧪 Interventions in This Study

• Norethindrone 0.35 MG (DRUG)
• Drospirenone (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Oregon Health & Science University — Portland, Oregon

📞 Contact the Study Coordinator

Phone: (503) 494-3666

Email: whru@ohsu.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Hypertension

• Implementing a Home Blood Pressure Monitoring Program in Primary Care — New York, New York
• SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Birmingham, Alabama
• Stress and Blood Pressure Management for Caregivers — Columbus, Ohio
• Caveolin-1 and Vascular Dysfunction — Boston, Massachusetts
• The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension — Birmingham, Alabama
• Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County — Irvine, California

Explore by condition: All Hypertension clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.